Highlights and Quick Summary
- Total non-current liabilities for the quarter ending March 31, 2022 was $8.43 Million (a 44.19% increase compared to previous quarter)
- Year-over-year quarterly Total non-current liabilities increased by 42.8%
- Annual Total non-current liabilities for 2021 was $5.85 Million (a -32.59% decrease from previous year)
- Annual Total non-current liabilities for 2020 was $8.67 Million (a -80.29% decrease from previous year)
- Annual Total non-current liabilities for 2019 was $44 Million (a 46.78% increase from previous year)
Visit stockrow.com/ORGS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total non-current liabilities of Orgenesis Inc.
Most recent Total non-current liabilitiesof ORGS including historical data for past 10 years.Interactive Chart of Total non-current liabilities of Orgenesis Inc.
Orgenesis Inc. Total non-current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $8.43 | – | – | – | – |
| 2021 | $5.85 | $8.38 | $5.9 | $8.43 | $5.85 |
| 2020 | $8.67 | $11.59 | $11.05 | $11.64 | $8.67 |
| 2019 | $43.98 | $44.14 | $44.74 | $41.62 | $43.98 |
| 2018 | $29.65 | $24.38 | $8.26 | $6.77 | $29.97 |
| 2017 | – | $8.84 | $8.6 | $10.22 | $8.84 |
| 2016 | – | $8.32 | $8.33 | $3.29 | $6.49 |
| 2015 | – | – | – | $28.7 | $28.71 |
| 2014 | – | – | – | $0.56 | $0.57 |
| 2013 | – | – | – | $1.16 | $1.16 |
| 2012 | $0.0 | – | – | – | $0.0 |
Business Profile of Orgenesis Inc.
Sector: Healthcare
Industry: Biotechnology